| Serial Number | 97363707 |
| Word Mark | TMALIN |
| Filing Date | Thursday, April 14, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 5, 2023 |
| Registration Number | 7159103 |
| Registration Date | Tuesday, September 5, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 7, 2023 |
| Translation of Words in Mark | The wording "TMALIN" has no meaning in a foreign language. |
| Goods and Services | Biochemical research and development; Biomedical research services; Biotechnology research; Chemical research; Chemical research and analysis; Chemistry consultation; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Professional consulting services and advice about agricultural chemistry; Providing medical and scientific research information in the field of clinical trials; Research and development in the field of antibody-drug conjugates; Research and development in the field of antibody conjugates; Research and development in the field of drug conjugates; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of antibodies; Research in the field of chemistry; Scientific research for medical purposes in the area of cancerous diseases; Scientific research in the nature of conducting clinical trials for others; Technology research in the field of pharmaceutical preparations and medical instruments; Testing of chemicals; Testing of cosmetics; Testing of pharmaceuticals |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 20, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, October 31, 2022 |
| First Use In Commerce Date | Monday, October 31, 2022 |
| Party Name | MediLink Therapeutics(Suzhou)Co.,Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Suzhou, Jiangsu 215000 CN |
| Party Name | MediLink Therapeutics(Suzhou)Co.,Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Suzhou, Jiangsu 215000 CN |
| Party Name | MediLink Therapeutics(Suzhou)Co.,Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Suzhou, Jiangsu 215000 CN |
| Event Date | Event Description |
| Tuesday, September 5, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 5, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Friday, August 4, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Thursday, August 3, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, August 3, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, July 18, 2023 | USE AMENDMENT FILED |
| Thursday, August 3, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, July 18, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, May 2, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 7, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 7, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 15, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 1, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 1, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, April 20, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 18, 2022 | NEW APPLICATION ENTERED |